FDA Drug Recalls

Recalls / Class II

Class IID-0437-2017

Product

Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.

Brand name
Furosemide
Generic name
Furosemide
Active ingredient
Furosemide
Route
Oral
NDCs
0054-3294, 0054-4297, 0054-8297, 0054-4299, 0054-8299, 0054-4301, 0054-8301, 0054-3298
FDA application
ANDA070434
Affected lot / code info
Lot# 660833A, Exp 08/31/18

Why it was recalled

Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Recalling firm

Firm
Roxane Laboratories, Inc.
Manufacturer
Hikma Pharmaceuticals USA Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1809 Wilson Rd, N/A, Columbus, Ohio 43228-9579

Distribution

Quantity
6493 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2016-12-22
FDA classified
2017-01-23
Posted by FDA
2017-02-01
Terminated
2017-12-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0437-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.